Gestational Surrogacy Program

Gestational surrogacy has now become an accepted option for couples experiencing fertility problems. Indications for surrogacy would include:

  • Women without a uterus due to congenital absence or surgical removal.
  • Women who have suffered repeated miscarriages and for whom the prospect of carrying a baby to term is very remote. In this group those,who have repeatedly failed to achieve pregnancy following IVF treatment, may be considered.
  • Women with certain medical conditions,which make pregnancy life-threatening but for whom the long term prospects for health are good, can also be considered.

This booklet discusses the types of surrogacy, the preliminary testing required, and the treatment process.

There are two distinct types of surrogates: the surrogate gestational mother (host uterus or gestational carrier) provides the gestational but not the genetic component for reproduction and the surrogate mother who will provide both the genetic and gestational component for reproduction (true surrogacy). The Fertility & IVF Center of Miami does not offer true surrogacy as a mode of treatment.

The surrogate will undergo an initial screening process, which involves:

  • Consult and exam with our physicians
  • Consult with a psychologist
  • Cervical culture for Gonorrhea, Chlamydia, Ureaplasma/Mycoplasma, and routine.
  • HIV I and II antibody screen
  • HIV screen by PCR
  • Cytomegalovirus antibody
  • Complete blood count
  • Chemistry panel
  • Blood group
  • Hepatitis panel
  • Rapid plasma reagent (syphilis)
  • Hysteroscopy

Preparation For Embryo Transfer

The surrogate prepares her uterus for the transfer of the embryos while the commissioning patient undergoes stimulation with fertility drugs. The goal is to re-create the hormonal changes that occur normally during a menstrual cycle by administering appropriate doses of hormones such as estradiol and progesterone. The desired effect on the uterus is the development of an appropriate implantation bed (uterine lining), capable of receiving an embryo. Estrogen is usually administered using patches (Vivelle dot) or in some instances orally. The use of the patch has the advantage of producing more consistent blood levels throughout the cycle and avoids the need for the oral intake of daily medication. Since hormone levels normally vary throughout the cycle, the number of patches will vary in a manner designed to increase the dose of estrogen.

The surrogate also begins subcutaneous daily injection of Lupron to suppress ovarian activities a week before expected menses. Once the surrogate’s period begins, a baseline ultrasound and blood work is performed to ensure that Lupron has achieved its goal of suppression.Once suppression is confirmed, the surrogate begins patches on a determined day designated as Cycle Day 1. It is very important not to begin any patch therapy until the commissioning female is ready to start fertility drugs.After 13 days of patches, the surrogate attends the office for an ultrasound and an estradiol level to ensure the adequate development of a uterine lining and proper levels of estradiol. If these tests are within normal limits, the recipient remains on the same medication regime or “holding pattern” until the commissioning female is ready for retrieval.

Once the eggs are retrieved, the surrogate begins nightly intramuscular injections of Progesterone. Progesterone is a steroid hormone that primes the uterus for embryo implantation.The fertilized eggs are left in culture to develop for 3 days. On the third day, the embryologist will observe the embryos and note the number, quality, and stage of development. Together with the physician, they will make a recommendation to leave the embryos in culture for an additional 2 days or transfer them that day. If a large number of good quality embryo exists, the embryos can be left in culture for an additional 2 days so that they may reach the stage of blastocyst.

 

Embryo Transfer

The number of embryos to be transferred to the uterus is usually discussed and outlined in the contract between the commissioning couple and the surrogate. The doctor and embryologist will inform the commissioning couple of number
of embryos available and their quality and give them their recommendation. The actual number of embryos to be transferred will be discussed among all parties at the time of transfer. Transfer of embryos is performed in our office in specially outfitted rooms.
An ultrasound is performed to verify the curvature of the cervix. The doctor places a speculum in the vagina and washes the cervix before introducing an empty catheter. This “practice run” will help the doctor place the catheter loaded with the embryos with ease. Following the transfer, the patient rests for 1 hour and then is discharged home. A pregnancy test is performed in the office 2 weeks after the eggs were retrieved.

 

Download Our Brochure

About The Sperm Chromatin Structure (SCSA) Test

The sperm Chromatin Structure Assay test is a flow cytometric assay that measures sperm DNA fragmentation and maturity. The test is completed on snap-frozen (no cryoprotectant), raw (no sperm washing) sperm collected after two to three days of sexual abstinence.

This test is used by physicians to determine if patients fall into a statistical category of men that are at increased risk for infertility. There SCSA® categories are based on the percentage of sperm that have sperm DNA fragmentation (DNA fragmentation Index, DFI) and immature chromatin structure (High DNA Stainability, HDS).

The results of the SCSA® test are interpreted by a high-complexity clinical laboratory director (HCLD, Board certified by the American Association of Bioanalyst) with over 20 years expertise in the development and interpretation of this highly complex test. SCSA Diagnostics, Inc. is approved by the Department of Health and Human Services (CLIA) providing assurance that the SCSA® test will be conducted to the highest standards and that patient data will be handled and archived in an appropriate manner.
SCSA® test results will be sent back to your referring physician from the Fertility & IVF Center of Miami, who may contact SCSA Diagnostics, Inc. directly for further consultation. Should a problem be detected, your phsycian will prescribe the best method of treatment.

SCSA® testing is often recommended by physicians when patients have conditions including:

  • Unexplained Infertility
  • Persistent Infertility after Treatment of Female
  • Recurrent Miscarriag
  • Prior to Assisted Reproductive Technologies
  • Cancer in Male: Before and After Treatment
  • Abnormal Semen Analysis
  • Advancing Male Age (>50years)

 

THIS IS A RELATIVELY NEW TEST; THERE IS NO ASSIGNED BILLING CODE FOR IT. YOUR INSURANCE WILL NOT COVER THIS TEST. YOU ARE RESPONSIBLE TO PAY $300.00

Services

The Center specializes in the hallmark of Assisted Conception: In Vitro Fertilization (IVF). We offer Ovulation Induction with Gonadotropin or Clomiphene Therapy. In addition, we have an active Gamete Donation Program (Egg Donor). Our doctors offer the most advanced surgical techniques with particular expertise in reconstructive surgery for the treatment of tubal disease, endometriosis, myomas, and reversal of tubal ligation surgery. Our doctors perform open, laparascopic and robotic (Da Vinci) surgeries depending on the patient’s needs.

Beyond our clinical expertise, we are dedicated to your holistic care, including working closely with psychologists for emotional support, urologists for evaluation of the male, and even acupuncturists for those seeking alternative treatments.

All laboratory testing and hormonal assessment is done on site for your convenience.

Our range of services include:

  • Clinical evaluation of infertility 

  • Laboratory evaluation of the infertile couple 

  • Evaluation of miscarriage and recurrent pregnancy loss 

  • In-Vitro-Fertilization (IVF) [+more info]

  • Intra-Cytoplasmic Sperm Injection (ICSI) [+more info]

  • Percutaneous Epididymal Sperm Aspiration (PESA) [+more info]

  • Testicular Sperm Aspiration (TESA) [+more info]

  • Assisted Hatching (AH) [+more info] 

  • Tubal reanastomosis (reversal of sterilization)

  • Pregnancy following female or male sterilization 

  • Gestational Surrogacy Program 

  • Our Egg Donor Program [+more info]

  • Donor Sperm Program 

  • Minimally Invasive Gynecological Surgery 

  • Laparoscopic Surgery 

  • Hysteroscopic Surgery 

  • Robotic Surgery 

  • Microscopic Surgery 

  • Pre-implantation Genetic Diagnosis (PGD), Pre-implantation Genetic Screening (PGS) for sex selection and diagnosis of certain genetic diseases

 

Additional information